FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to dermatology, and can be used for treating keloids or hypertrophic scars. Method according to invention involves introduction of composition containing modified oligonucleotide. Kit comprises device filled with composition and instructions for its use.
EFFECT: use of inventions enables reducing intensity and formation of hypertrophic scars and keloids due to delivery of antisense nucleotide in point of damage by longitudinal injection.
76 cl, 3 tbl, 7 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODULATION OF ANDROGEN RECEPTOR EXPRESSION | 2013 |
|
RU2670486C9 |
| COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF DYSTROPHIC MIOTONIN-PROTEINKINASE (DMPK) | 2014 |
|
RU2690333C2 |
| ANTISENSE MODULATION OF GCGR EXPRESSION | 2012 |
|
RU2598709C2 |
| MODULATING EXPRESSION OF ANGIOPOIETIN-LIKE PROTEIN 3 | 2014 |
|
RU2706964C2 |
| COMPOSITIONS FOR MODULATION OF ATAXIN 2 EXPRESSION | 2015 |
|
RU2702838C2 |
| CANCER TREATMENT | 2013 |
|
RU2689548C2 |
| COMPOSITIONS AND METHODS OF SML2 SPLICING MODULATION IN SUBJECT | 2010 |
|
RU2683772C2 |
| MODULATION OF THE EXPRESSION OF APOLIPOPROTEIN C-III (APOSIII) IN THE PATIENTS WITH LIPODYSTROPHY | 2016 |
|
RU2737719C2 |
| COMPOSITIONS AND METHODS OF MODULATING SMN2 SPLICING IN SUBJECT | 2010 |
|
RU2566724C9 |
| COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT | 2019 |
|
RU2793459C2 |
